Article Versions Notes

Mitsueda R, Nagata A, Toda H, Tomioka Y, Yasudome R, Kato M, Shinden Y, Nakajo A, Seki N. Identification of Tumor-Suppressive miR-30a-3p Controlled Genes: ANLN as a Therapeutic Target in Breast Cancer. Non-Coding RNA. 2024; 10(6):60. https://doi.org/10.3390/ncrna10060060

Mitsueda, Reiko, Ayako Nagata, Hiroko Toda, Yuya Tomioka, Ryutaro Yasudome, Mayuko Kato, Yoshiaki Shinden, Akihiro Nakajo, and Naohiko Seki. 2024. "Identification of Tumor-Suppressive miR-30a-3p Controlled Genes: ANLN as a Therapeutic Target in Breast Cancer" Non-Coding RNA 10, no. 6: 60. https://doi.org/10.3390/ncrna10060060

Mitsueda, R., Nagata, A., Toda, H., Tomioka, Y., Yasudome, R., Kato, M., Shinden, Y., Nakajo, A., & Seki, N. (2024). Identification of Tumor-Suppressive miR-30a-3p Controlled Genes: ANLN as a Therapeutic Target in Breast Cancer. Non-Coding RNA, 10(6), 60. https://doi.org/10.3390/ncrna10060060